Publication | Open Access

Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma – Results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience

Hepatic DisordersHepatologyFibrolamellar VariantMedicinePathologyLiver DiseaseLiver CancerHepatology FibrosisOncologyRadiation OncologyHepatocellular CarcinomaBetter Survival